Welcome to The Symptoms Of Multiple Sclerosis
Multiple Sclerosis Walk Article
This is a selection among article about Multiple Sclerosis Walk. For a permanent link to this article, or to bookmark it for further reading, click here.
Life-Saving Pediatric Drug Becomes Readily Available to Those in Need
from: By: ARA Content(ARA) - We can all sympathize with the frustration people experience waiting for a new drug that is being tested for a certain disorder. Imagine you have a child with a rare disorder and the only drug effective for treating the disorder is not only extremely hard to obtain, but available only through a nationally-administered random selection process. For many American families, this dilemma is a harsh reality.
Patients suffering from a host of difficult to treat orphan disorders have found marked relief from using HP Acthar Gel. Some disorders Acthar helps include seizure complex in babies and young children, referred to as West's syndrome or infantile spasm; Still's disease and ulcerative colitis; Bell's palsy; multiple sclerosis; adrenocortical insufficiency and non-endocrine disorders that are responsive to glucocorticoids.
For the past four years, however, the drug has only been available through a limited access program administered by the National Organization for Rare Disorders (NORD), a federation of more that 135 non-profit health organizations serving people with rare disorders.
U.S. physicians who were interested in obtaining Acthar Gel for their patients with life-threatening or severely debilitating conditions who did not respond to any other treatment were given first access to the drug. Others with "non-life-threatening" cases had to enroll in a computerized random selection process administered by NORD.
An estimated 1,600 patients, primarily suffering from West's syndrome and multiple sclerosis who experience episodes of "flare," have been allowed access to HP Acthar Gel each year for the past four years under the limited access program. More than 5,000 additional patients whose physicians requested the drug were denied.
The origins of this drug shortage crisis date back to 1996 when Aventis Pharmaceuticals stopped making Acthar for a few months because of manufacturing difficulties.
But now, Questcor Pharmaceuticals, Inc. (AMEX: QSC) has signed an agreement with Aventis to acquire the worldwide rights to HP Acthar Gel. Questcor has also reached a manufacturing agreement with Aventis and will gradually move production to an independent manufacturing facility.
As a result, HP Acthar Gel is now back in full production and is returning to normal levels of distribution. Questcor began shipments of HP Acthar Gel to wholesalers the last week of September 2001, giving patients in need access to the product.
"We are delighted that Questcor is making this critically important product more widely available after this long period of restricted distribution," said Abbey S. Meyers, president of NORD. "We have been working closely with the company over the last several months to ensure that anyone with a need for Acthar Gel is now able to readily receive the product through more traditional channels. Too many people have suffered as a result of limited access to Acthar Gel."
Questcor Pharmaceuticals, Inc. is a fully integrated specialty pharmaceutical company that serves the needs of acute and critical care hospitals with its proprietary products. Visit www.questcor.com for more information on the company and its products.
If you are a patient with a disorder that can be treated with Acthar, ask your doctor to contact Questcor Pharmaceuticals at (510) 400-0700. For more information about Acthar, including distribution information, please visit www.Acthar.com.
About The Author Courtesy ARA Content, www.ARAcontent.com; e-mail: info@ARAcontent.com |
This article was posted on January 17, 2002
Multiple Sclerosis Walk News
Shelley Cason plans to walk 50 miles for MS
Sharon Kant-Rauch Democrat staff writer -- The MS Challenge Walk in March will raise money for a cure for multiple sclerosis.
Read more...Join Team WTOC for MS Walk Savannah to fight multiple sclerosis
The MS Walk Savannah is at the end of March, but fund-raising has begun. Team WTOC wants you to walk with us and help raise money to find a cure for multiple sclerosis.
Read more...Patients Report Controversial Multiple Sclerosis Treatment Improves Their Lives: Presented at ISET 2012
Although using angioplasty to treat multiple sclerosis is highly controversial, sufferers often insist it helps – in some cases dramatically, such as allowing them to walk without a cane.
Read more...MS Society honors longtime supporter
Carol L. Lasek was awarded the distinguished Hope Award by The National Multiple Sclerosis Society, South Florida Chapter, at its 29th Annual MS Gala & Fashion Show. About 1,000 people attended the prestigious fundraiser that was presented by DBS Financial Group/MassMutual at the Broward County Convention Center.
Read more...Muscling in on multiple sclerosis
Multiple sclerosis (MS), a neurodegenerative disease, causes periodic attacks of neurologic symptoms such as limb weakness and mobility defects. And while MS patients' walking abilities and muscle strength are examined on a regular basis, doctors have yet to determine when the lower limb muscles begin to deteriorate. That's important because with earlier identification of mobility problems ...
Read more...
Small business development & consulting firm.